TCL Archive “Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor November 8, 2013
TCL Archive Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting June 20, 1986
TCL Archive Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down May 31, 2013